Lenox Wealth Management, Inc. - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 16 filers reported holding Astellas Pharma Inc in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lenox Wealth Management, Inc. ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2020$3,0000.0%229
+7.0%
0.00%0.0%
Q1 2020$3,000
+200.0%
214
+239.7%
0.00%
Q4 2019$1,000630.0%0.00%
Q3 2019$0
-100.0%
63
-59.4%
0.00%
-100.0%
Q2 2019$2,0000.0%155
+40.9%
0.00%0.0%
Q1 2019$2,0000.0%110
-25.7%
0.00%0.0%
Q4 2018$2,000
-71.4%
148
-75.4%
0.00%
-50.0%
Q3 2018$7,000
-12.5%
601
+19.7%
0.00%
-33.3%
Q2 2018$8,0005020.00%
Other shareholders
Astellas Pharma Inc shareholders Q3 2019
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders